Insider · CIK 0001849740
Bhavesh Ashar
officer
Files at SWTX (SpringWorks Therapeutics, Inc.). First filing Feb 24, 2025, latest Feb 24, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $62k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 17Weak | SpringWorks Therapeutics, Inc. | $62k 1,016 shares | -2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 20, 2025 | SWTX SpringWorks Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,016 | $61.19 | $62k | 62,053 | Feb 24, 2025 |
| Jan 10, 2025 | SWTX SpringWorks Therapeutics, Inc. | AGrant or award Common Stock | +17,323 | $0.00 | $0 | 63,069 | Jan 14, 2025 |
| Jan 10, 2025 | SWTX SpringWorks Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +50,615 | $0.00 | $0 | 50,615 | Jan 14, 2025 |
| Jan 4, 2025 | SWTX SpringWorks Therapeutics, Inc. | FTax withholding Common Stock | -4,475 | $38.19 | $171k | 51,855 | Jan 7, 2025 |
| Jan 5, 2025 | SWTX SpringWorks Therapeutics, Inc. | FTax withholding Common Stock | -3,825 | $38.19 | $146k | 48,030 | Jan 7, 2025 |
| Jan 6, 2025 | SWTX SpringWorks Therapeutics, Inc. | FTax withholding Common Stock | -2,284 | $38.86 | $89k | 45,746 | Jan 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.